2Y04
TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND PARTIAL AGONIST SALBUTAMOL
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-2 |
Synchrotron site | ESRF |
Beamline | ID23-2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009-06-26 |
Detector | MARRESEARCH |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 89.900, 62.000, 101.500 |
Unit cell angles | 90.00, 109.90, 90.00 |
Refinement procedure
Resolution | 95.400 - 3.050 |
R-factor | 0.22484 |
Rwork | 0.223 |
R-free | 0.25518 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2vt4 |
RMSD bond length | 0.012 |
RMSD bond angle | 1.438 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 38.600 | 3.210 |
High resolution limit [Å] | 3.050 | 3.050 |
Rmerge | 0.120 | 0.510 |
Number of reflections | 19354 | |
<I/σ(I)> | 7.7 | 1.8 |
Completeness [%] | 95.5 | 89.5 |
Redundancy | 2.9 | 2.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 9 | 277 | SITTING DROP VAPOUR DIFFUSION, PROTEIN (16.5MG/ML) IN 100MM NACL, 0.1MM EDTA, 1.0MM (R, S)-SALBUTAMOL, 1.0MG/ML CHS, 0.5% HEGA-10, 0.1M BICINE PH9.0, 28% PEG400 AT 4 DEGREES C |